Logo image of ENVIP.OL

ENVIPCO HOLDING NV (ENVIP.OL) Stock Fundamental Analysis

OSL:ENVIP - Euronext Oslo - NL0015000GX8 - Common Stock - Currency: NOK

86.2  +1.8 (+2.13%)

Fundamental Rating

3

ENVIP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 102 industry peers in the Machinery industry. The financial health of ENVIP is average, but there are quite some concerns on its profitability. ENVIP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ENVIP had negative earnings in the past year.
ENVIP had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ENVIP reported negative net income in multiple years.
In multiple years ENVIP reported negative operating cash flow during the last 5 years.
ENVIP.OL Yearly Net Income VS EBIT VS OCF VS FCFENVIP.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

ENVIP's Return On Assets of -2.64% is on the low side compared to the rest of the industry. ENVIP is outperformed by 78.43% of its industry peers.
The Return On Equity of ENVIP (-4.91%) is worse than 76.47% of its industry peers.
ENVIP's Return On Invested Capital of 1.40% is on the low side compared to the rest of the industry. ENVIP is outperformed by 77.45% of its industry peers.
Industry RankSector Rank
ROA -2.64%
ROE -4.91%
ROIC 1.4%
ROA(3y)-1.73%
ROA(5y)-1.7%
ROE(3y)-4.84%
ROE(5y)-4.16%
ROIC(3y)N/A
ROIC(5y)N/A
ENVIP.OL Yearly ROA, ROE, ROICENVIP.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

ENVIP has a Operating Margin of 1.30%. This is in the lower half of the industry: ENVIP underperforms 79.41% of its industry peers.
ENVIP's Gross Margin of 37.08% is in line compared to the rest of the industry. ENVIP outperforms 45.10% of its industry peers.
In the last couple of years the Gross Margin of ENVIP has remained more or less at the same level.
Industry RankSector Rank
OM 1.3%
PM (TTM) N/A
GM 37.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.6%
GM growth 5Y-0.44%
ENVIP.OL Yearly Profit, Operating, Gross MarginsENVIP.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ENVIP is destroying value.
The number of shares outstanding for ENVIP has been increased compared to 1 year ago.
The number of shares outstanding for ENVIP has been increased compared to 5 years ago.
Compared to 1 year ago, ENVIP has an improved debt to assets ratio.
ENVIP.OL Yearly Shares OutstandingENVIP.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ENVIP.OL Yearly Total Debt VS Total AssetsENVIP.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ENVIP has an Altman-Z score of 5.39. This indicates that ENVIP is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 5.39, ENVIP belongs to the best of the industry, outperforming 93.14% of the companies in the same industry.
A Debt/Equity ratio of 0.13 indicates that ENVIP is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.13, ENVIP belongs to the best of the industry, outperforming 80.39% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 5.39
ROIC/WACC0.19
WACC7.38%
ENVIP.OL Yearly LT Debt VS Equity VS FCFENVIP.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 2.03 indicates that ENVIP has no problem at all paying its short term obligations.
The Current ratio of ENVIP (2.03) is better than 73.53% of its industry peers.
A Quick Ratio of 1.25 indicates that ENVIP should not have too much problems paying its short term obligations.
ENVIP has a better Quick ratio (1.25) than 69.61% of its industry peers.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.25
ENVIP.OL Yearly Current Assets VS Current LiabilitesENVIP.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

6

3. Growth

3.1 Past

ENVIP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -162.50%.
Looking at the last year, ENVIP shows a small growth in Revenue. The Revenue has grown by 6.47% in the last year.
The Revenue has been growing by 26.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-162.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1829.17%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y45.27%
Revenue growth 5Y26.59%
Sales Q2Q%-23.46%

3.2 Future

The Earnings Per Share is expected to grow by 379.32% on average over the next years. This is a very strong growth
ENVIP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 50.92% yearly.
EPS Next Y1528%
EPS Next 2Y634.98%
EPS Next 3Y379.32%
EPS Next 5YN/A
Revenue Next Year32.37%
Revenue Next 2Y43.56%
Revenue Next 3Y50.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ENVIP.OL Yearly Revenue VS EstimatesENVIP.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
ENVIP.OL Yearly EPS VS EstimatesENVIP.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6 0.8 1

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ENVIP. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 14.02 indicates a correct valuation of ENVIP.
ENVIP's Price/Forward Earnings is on the same level as the industry average.
ENVIP's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 37.13.
Industry RankSector Rank
PE N/A
Fwd PE 14.02
ENVIP.OL Price Earnings VS Forward Price EarningsENVIP.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

80.39% of the companies in the same industry are cheaper than ENVIP, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 40.39
ENVIP.OL Per share dataENVIP.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

ENVIP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ENVIP's earnings are expected to grow with 379.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y634.98%
EPS Next 3Y379.32%

0

5. Dividend

5.1 Amount

No dividends for ENVIP!.
Industry RankSector Rank
Dividend Yield N/A

ENVIPCO HOLDING NV

OSL:ENVIP (7/30/2025, 7:00:00 PM)

86.2

+1.8 (+2.13%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)08-13 2025-08-13
Inst Owners34.78%
Inst Owner ChangeN/A
Ins Owners35.17%
Ins Owner ChangeN/A
Market Cap4.97B
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-53.1%
Min EPS beat(2)-75.49%
Max EPS beat(2)-30.72%
EPS beat(4)0
Avg EPS beat(4)-101.06%
Min EPS beat(4)-149.02%
Max EPS beat(4)-30.72%
EPS beat(8)3
Avg EPS beat(8)-46.73%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-8.69%
Min Revenue beat(2)-24.86%
Max Revenue beat(2)7.48%
Revenue beat(4)1
Avg Revenue beat(4)-9.89%
Min Revenue beat(4)-24.86%
Max Revenue beat(4)7.48%
Revenue beat(8)3
Avg Revenue beat(8)-2.71%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.02
P/S 3.78
P/FCF N/A
P/OCF 187.54
P/B 6.54
P/tB 8.46
EV/EBITDA 40.39
EPS(TTM)-0.59
EYN/A
EPS(NY)6.15
Fwd EY7.13%
FCF(TTM)-0.92
FCFYN/A
OCF(TTM)0.46
OCFY0.53%
SpS22.82
BVpS13.18
TBVpS10.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.64%
ROE -4.91%
ROCE 1.82%
ROIC 1.4%
ROICexc 1.88%
ROICexgc 2.5%
OM 1.3%
PM (TTM) N/A
GM 37.08%
FCFM N/A
ROA(3y)-1.73%
ROA(5y)-1.7%
ROE(3y)-4.84%
ROE(5y)-4.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.6%
GM growth 5Y-0.44%
F-Score6
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA 0.83
Cap/Depr 76.62%
Cap/Sales 6.04%
Interest Coverage 250
Cash Conversion 21.93%
Profit Quality N/A
Current Ratio 2.03
Quick Ratio 1.25
Altman-Z 5.39
F-Score6
WACC7.38%
ROIC/WACC0.19
Cap/Depr(3y)125.69%
Cap/Depr(5y)118.36%
Cap/Sales(3y)9.77%
Cap/Sales(5y)10.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-162.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1829.17%
EPS Next Y1528%
EPS Next 2Y634.98%
EPS Next 3Y379.32%
EPS Next 5YN/A
Revenue 1Y (TTM)6.47%
Revenue growth 3Y45.27%
Revenue growth 5Y26.59%
Sales Q2Q%-23.46%
Revenue Next Year32.37%
Revenue Next 2Y43.56%
Revenue Next 3Y50.92%
Revenue Next 5YN/A
EBIT growth 1Y-74.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year345.56%
EBIT Next 3Y142.35%
EBIT Next 5YN/A
FCF growth 1Y86.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y109.23%
OCF growth 3Y34.86%
OCF growth 5Y8.65%